Literature DB >> 20658380

Mental disorders in suicide and undetermined death in the Lundby Study. The contribution of severe depression and alcohol dependence.

Louise Brådvik1, Cecilia Mattisson, Mats Bogren, Per Nettelbladt.   

Abstract

To evaluate the role of severe depression, i.e., depression with melancholic and/or psychotic features and alcohol dependence in suicide and undetermined death. The Lundby Study is a prospective, longitudinal study of a population consisting of 3563 subjects. In a long-term follow up 1947-2006 there were 66 suicide cases, including 19 undetermined deaths. Depression and alcoholism were as expected the major contributors to suicide (44% and 23% respectively). Severe depression with psychotic and/or melancholic features was diagnosed in 66% of all depressions and in 29% of all suicide cases, as compared to 15% for major depression only. Alcohol dependence was related to undetermined death. Major depressive disorder with melancholic and/or psychotic features appears to be an important contributor to accomplished suicide in the depression group, and alcohol dependence appears to be related to undetermined death.

Entities:  

Mesh:

Year:  2010        PMID: 20658380     DOI: 10.1080/13811118.2010.494146

Source DB:  PubMed          Journal:  Arch Suicide Res        ISSN: 1381-1118


  14 in total

1.  Characteristics of suicides among US army active duty personnel in 17 US states from 2005 to 2007.

Authors:  Joseph Logan; Nancy A Skopp; Debra Karch; Mark A Reger; Gregory A Gahm
Journal:  Am J Public Health       Date:  2012-01-25       Impact factor: 9.308

Review 2.  Anxiety and its disorders as risk factors for suicidal thoughts and behaviors: A meta-analytic review.

Authors:  Kate H Bentley; Joseph C Franklin; Jessica D Ribeiro; Evan M Kleiman; Kathryn R Fox; Matthew K Nock
Journal:  Clin Psychol Rev       Date:  2015-12-02

3.  Repetition of suicide attempts across episodes of severe depression. Behavioural sensitisation found in suicide group but not in controls.

Authors:  Louise Brådvik; Mats Berglund
Journal:  BMC Psychiatry       Date:  2011-01-07       Impact factor: 3.630

4.  Reduced Synaptic Plasticity Contributes to Resistance Against Constant-Stimulus Electroconvulsive Treatment in a Rat Model of Stress-Induced Depression.

Authors:  Bin Wu; Yuanyuan Guo; Jie Deng; Qibin Chen; Su Min
Journal:  Neuropsychiatr Dis Treat       Date:  2021-05-11       Impact factor: 2.570

5.  Air pollution and emergency department visits for suicide attempts in vancouver, Canada.

Authors:  Mieczysław Szyszkowicz; Jeff B Willey; Eric Grafstein; Brian H Rowe; Ian Colman
Journal:  Environ Health Insights       Date:  2010-10-15

6.  Antidepressant therapy in severe depression may have different effects on ego-dystonic and ego-syntonic suicidal ideation.

Authors:  Louise Brådvik; Mats Berglund
Journal:  Depress Res Treat       Date:  2011-05-12

7.  Suicidal Career in Severe Depression among Long-Term Survivors: In a Followup after 37-53 Years Suicide Attempts Appeared to End Long before Depression.

Authors:  Lisa Crona; Alexander Mossberg; Louise Brådvik
Journal:  Depress Res Treat       Date:  2013-12-23

8.  Clinical Prediction of Suicide and Undetermined Death: A Pseudo-Prospective Clinical and Medico-Legal Study of Substance Abusers.

Authors:  Louise Brådvik; Mats Berglund; Arne Frank; Peter Löwenhielm
Journal:  Int J Environ Res Public Health       Date:  2017-03-17       Impact factor: 3.390

9.  Taking care of oneself by regaining control - a key to continue living four to five decades after a suicide attempt in severe depression.

Authors:  Lisa Crona; Margaretha Stenmarker; Agneta Öjehagen; Ulrika Hallberg; Louise Brådvik
Journal:  BMC Psychiatry       Date:  2017-02-13       Impact factor: 3.630

10.  Antidepressant Utilization and Suicide in Europe: An Ecological Multi-National Study.

Authors:  Ricardo Gusmão; Sónia Quintão; David McDaid; Ella Arensman; Chantal Van Audenhove; Claire Coffey; Airi Värnik; Peeter Värnik; James Coyne; Ulrich Hegerl
Journal:  PLoS One       Date:  2013-06-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.